Filing Details
- Accession Number:
- 0001140361-13-014606
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-03-29 17:12:18
- Reporting Period:
- 2012-10-15
- Filing Date:
- 2013-03-29
- Accepted Time:
- 2013-03-29 17:12:18
- Original Submission Date:
- 2012-10-17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466630 | A Timothy Dick | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-10-15 | 54,900 | $1.00 | 72,980 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-15 | 54,900 | $12.71 | 18,080 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-10-16 | 45,100 | $1.00 | 63,180 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-10-16 | 45,100 | $13.00 | 18,080 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $12.6730 to $13.0335 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Includes additional purchases of Akorn Common Stock through Akorn's Employee Stock Purchase Plan of 7,352 shares on October 1, 2009, 7,389 shares on January 4, 2010 and 4,118 shares on January 18, 2012.
- Reflects the weighted average sale prices of the shares sold. The shares were sold in multiple trades at prices ranging from $13.0000 to $13.0050 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
Billionaire Hedge Funds
